BRAF plus MEK-targeted drugs: a new standard of treatment for BRAF-mutant advanced melanoma

Paola Queirolo, Francesco Spagnolo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'BRAF plus MEK-targeted drugs: a new standard of treatment for BRAF-mutant advanced melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences